Jul 17, 2025 8:00am EDT DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer
Jun 24, 2025 8:30am EDT DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
May 22, 2025 8:30am EDT DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025
May 19, 2025 9:00am EDT DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
May 14, 2025 4:30pm EDT DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025
May 13, 2025 4:30pm EDT DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights
May 08, 2025 4:00pm EDT DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May
May 07, 2025 8:30am EDT DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025
Mar 17, 2025 4:30pm EDT DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results
Mar 11, 2025 8:23am EDT DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025
